Swedish Medical Center

Futó vizsgálatok

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· 3. fázis· Prilenia· Forrás

• Toboroz

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  NCT07222800· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

  NCT07074886· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

  NCT07120945· Medtronic - MITG· Forrás

• Toboroz

  Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

  NCT06896916· 1. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· 2. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Toboroz

  Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  NCT06855277· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  NCT06902558· 2. fázis· Calico Life Sciences LLC· Forrás

• Fut, nem toboroz

  Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

  NCT06898957· 1. fázis· Amgen· Forrás

• Toboroz

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

  NCT06646276· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  NCT06618287· 1/2. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

  NCT06556563· 3. fázis· NovoCure GmbH· Forrás

• Fut, nem toboroz

  Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

  NCT06691984· 3. fázis· Amgen· Forrás

• Toboroz

  Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

  NCT06631287· 3. fázis· Wes Ely· Forrás

• Fut, nem toboroz

  TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

  NCT06137807· P+F Products + Features USA Inc.· Forrás

• Toboroz

  Global Paradise System US Post Approval Study

  NCT06297291· ReCor Medical, Inc.· Forrás

• Toboroz

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· 3. fázis· Immunocore Ltd· Forrás

• Toboroz

  A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  NCT06234605· 1. fázis· HiberCell, Inc.· Forrás

• Fut, nem toboroz

  Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

  NCT06294236· 1. fázis· Sana Biotechnology· Forrás

• Toboroz

  Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

  NCT05380349· Korai 1. fázis· Swedish Medical Center· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

  NCT06220201· 1. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Meghívásos bevonás

  ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

  NCT05932615· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06191744· 3. fázis· Genmab· Forrás

• Toboroz

  A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  NCT06153251· 1. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Fut, nem toboroz

  The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

  NCT05820087· HistoSonics, Inc.· Forrás

• Fut, nem toboroz

  Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

  NCT06141486· 3. fázis· Sanofi· Forrás

• Toboroz

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

  NCT06141473· 3. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

  NCT06003231· 2. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás

• Toboroz

  A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  NCT06095089· 1. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  NCT05894239· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

  NCT05696444· Medtronic - MITG· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

  NCT05347095· 3. fázis· Janssen-Cilag Ltd.· Forrás

• Fut, nem toboroz

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· 2. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

  NCT05047172· 3. fázis· University of Florida· Forrás

• Fut, nem toboroz

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· 2. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

  NCT05283720· 2. fázis· Genmab· Forrás

• Meghívásos bevonás

  A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)

  NCT05352919· 3. fázis· Biogen· Forrás

• Fut, nem toboroz

  A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

  NCT05090371· 4. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Assessment of CCM in HF With Higher Ejection Fraction

  NCT05064709· Impulse Dynamics· Forrás

• Fut, nem toboroz

  Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

  NCT04910022· 1/2. fázis· Nerviano Medical Sciences· Forrás

• Toboroz

  PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

  NCT04889872· Edwards Lifesciences· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· 4. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04961567· 3. fázis· Biogen· Forrás

Showing 50 of 79.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák6 toboroz
• Prosztatarák3 toboroz
• Aortic stenosis2 toboroz
• Áttétes emlőrák2 toboroz
• Mielóma multiplex2 toboroz
• Petefészekrák2 toboroz
• Szívelégtelenség2 toboroz
• Amiotrófiás laterálszklerózis (ALS)1 toboroz
• Colitis ulcerosa1 toboroz
• Elhízás1 toboroz
• Fej-nyaki daganatok1 toboroz
• Glioblasztóma1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hólyagrák1 toboroz
• Long COVID és ME/CFS1 toboroz
• Lupus (SLE)1 toboroz
• Magas vérnyomás1 toboroz
• Méhnyakrák1 toboroz
• Melanóma1 toboroz
• Pitvarfibrilláció1 toboroz
• Policisztás vesebetegség1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vastagbélrák1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Toboroz

  Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  NCT06486454· HistoSonics, Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  NCT06430801· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

  NCT05966662· Shockwave Medical, Inc.· Forrás

• Lezárult

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· NYU Langone Health· Forrás

• Lezárult

  A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

  NCT05071664· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

  NCT05024045· 1. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· 2. fázis· Pfizer· Forrás

• Toboroz

  Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  NCT03907046· 3. fázis· Yale University· Forrás

• Lezárult

  A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

  NCT03740529· 1/2. fázis· Loxo Oncology, Inc.· Forrás

• Lezárult

  A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

  NCT03833180· 1. fázis· VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)· Forrás

• Lezárult

  Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

  NCT03797326· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Lipoic Acid for Progressive Multiple Sclerosis (MS)

  NCT03161028· 2. fázis· VA Office of Research and Development· Forrás

• Leállították

  A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

  NCT03530683· 1. fázis· Pfizer· Forrás

• Lezárult

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· 3. fázis· CSL Behring· Forrás

• Leállították

  Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

  NCT03382977· 1/2. fázis· VBI Vaccines Inc.· Forrás

• Lezárult

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Sino Medical Sciences Technology Inc.· Forrás

• Lezárult

  A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

  NCT03069352· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

  NCT03104374· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

  NCT03104400· 3. fázis· AbbVie· Forrás

• Lezárult

  AMPLATZER™ Amulet™ LAA Occluder Trial

  NCT02879448· Abbott Medical Devices· Forrás

• Lezárult

  A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

  NCT02675231· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

  NCT02486718· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Mayo Clinic· Forrás

• Lezárult

  A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

  NCT02163694· 3. fázis· AbbVie· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Arthritis psoriatica46 munka · 4 vizsgálat
• Pikkelysömör20 munka · 4 vizsgálat
• Spondylitis ankylopoetica (Bechterew-kór)9 munka · 0 vizsgálat